Combination Treatment for Augmenting Language in Children With ASD

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Autism Spectrum Disorder
Interventions
BEHAVIORAL

Behavioral Therapy

Thrice-weekly individually based language JAE-EMT intervention will be provided by a trained therapist and taught to the child and their caregivers. A total of 36 sessions will be provided over 12 weeks, with 2 per week at UCLA, and one session per week in the home.

DRUG

Aripiprazole

50% of the subjects will be randomized to aripiprazole (active study medication)

DRUG

Placebo

50% of the subjects will be randomized to placebo (inactive study medication).

Trial Locations (1)

90095

University of California, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT02574741 - Combination Treatment for Augmenting Language in Children With ASD | Biotech Hunter | Biotech Hunter